Kenya Approves Moderna, Sinopharm Vaccines Amid Fourth Wave

Kenya granted emergency use authorization for Moderna Inc and Sinopharm Group Co. Covid-19 vaccines, said Pharmacy and Poisons Board Chief Executive Officer Fred Siyoi.

The East African nation will receive two million Sinopharm doses, with the first batch of 200,000 shots donated by China expected in September, Willis Akhwale, head of its vaccine advisory team, said in a separate interview. It also expects 1.76 million doses of Moderna, with an initial 800,000 shots arriving in Nairobi next week.